Cohen Yuval's Stock Option Exercise and Sale Plan

Cohen Yuval, an officer of Corbus Pharmaceuticals Holdings, Inc., has filed a Form 144 to report the planned sale of 27,633 shares of common stock acquired through a stock option exercise. The shares were acquired on February 13, 2023, and the sale is planned for October 24, 2025. The aggregate market value of the shares to be sold is approximately $469,977. The transaction is part of an equity compensation plan adopted on March 14, 2025. The sale will be executed through Stifel Nicolaus & Company Inc. There are no recent transactions to report in the past three months.